Revvity, Inc. (RVTY)

NYQ – Real vaqt narxi. Valyuta: USD

99.30

+0.35 (0.35%)

Yopilishda: May 12, 2026, 4:00 PM EDT

98.20

-1.08 (-1.09%)

Bozor oldidan: May 13, 2026, 8:26 AM EDT

05.05.2026

RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution

Revvity beat Q1 EPS and revenue estimates as 3% organic growth and portfolio execution offset margin pressure and China ImmunoDx divest plans.

05.05.2026

Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript

05.05.2026

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

05.05.2026

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity (RVTY) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.01 per share a year ago.

05.05.2026

Revvity Announces Financial Results for the First Quarter of 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the first quarter ended April 5, 2026. The Company reported GAAP earnings per share from continuing operations of $0.37, as compared to $0.35 in the same period a year ago. Revenue for the quarter was $711 million, as compared to $665 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $76 million, as compared to $72 million for the same perio.

04.05.2026

Revvity to Report Q1 Earnings: What's in Store for the Stock?

RVTY heads into Q1 earnings with Diagnostics strength and Life Sciences stabilization, but China pressures and weak academic demand may temper near-term growth.

16.04.2026

Revvity to Present at Upcoming Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: BofA Securities 2026 Health Care Conference Wednesday, May 13, 2026 9:20 a.m. PT - Steve Willoughby, senior vice president, investor relations, ESG, risk Goldman Sachs 47th Annual Global Healthcare Conference Tuesday, June 9, 2026 8:40 a.m. ET - Prahlad Singh, president and chief executive officer Attendees will receive an update on the Company and its strategic pr.

Videolar

No Data

There is no data to display

Press-relizlar

05.05.2026

Revvity Announces Financial Results for the First Quarter of 2026

10.04.2026

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2026 financial results prior to market open on Tuesday, May 5, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call. To access the call, a live audio webcast will be available on the Investors section of the.

09.04.2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business is launching Signals BioDesignTM, a cloud-native molecular cloning solution that streamlines biologics research workflows. Built for biotech and pharma R&D teams, the platform simplifies complex cloning processes and enables scalable, collaborative development in a unified digital environment. It addresses the limitations of desktop tools and overly complex platforms by combining.

05.02.2026

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

WALTHAM, Mass.--(BUSINESS WIRE)-- #LifeSciences--Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, are the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation, alongside other recently introduced solutions spanning sample preparation,.

Revvity, Inc. (RVTY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Revvity, Inc. (RVTY)

RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution

Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Report Q1 Earnings: What's in Store for the Stock?

Revvity to Present at Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution

Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Report Q1 Earnings: What's in Store for the Stock?

Revvity to Present at Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

Search stocks

Revvity, Inc. (RVTY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Revvity, Inc. (RVTY)

RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution

Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Report Q1 Earnings: What's in Store for the Stock?

Revvity to Present at Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution

Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Report Q1 Earnings: What's in Store for the Stock?

Revvity to Present at Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026